Skip to main content
. 2018 Sep-Oct;34(5):1064–1069. doi: 10.12669/pjms.345.15574

Table-VI.

Incidence rates of adverse reactions.

Group Case No. Hyposexuality Bone mineral density abnormality Abnormal vaginal bleeding Liver dysfunction Total adverse reactions
A 50 1 (2) 0 1 (2) 2 (4) 4 (8)
B 50 0 1 (2) 1 (2) 1 (2) 3 (6)
C 50 1 (2) 0 2 (4) 1 (2) 4 (8)

Compared with Group-A, *P<0.05.